Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Iron, Hepcidin, and Death in Human AKI.

Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Boerger EAS, Mc Causland FR, Eisenga MF, Singh K, Babitt JL, Kellum JA, Palevsky PM, Christov M, Waikar SS.

J Am Soc Nephrol. 2019 Feb 8. pii: ASN.2018100979. doi: 10.1681/ASN.2018100979. [Epub ahead of print]

PMID:
30737269
2.

Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients.

Eisenga MF, Gomes-Neto AW, van Londen M, Ziengs AL, Douwes RM, Stam SP, Osté MCJ, Knobbe TJ, Hessels NR, Buunk AM, Annema C, Siebelink MJ, Racz E, Spikman JM, Bodewes FAJA, Pol RA, Berger SP, Drost G, Porte RJ, Leuvenink HGD, Damman K, Verschuuren EAM, de Meijer VE, Blokzijl H, Bakker SJL.

BMJ Open. 2018 Dec 31;8(12):e024502. doi: 10.1136/bmjopen-2018-024502.

3.

Active smoking and macrocytosis in the general population: Two population-based cohort studies.

Eisenga MF, Wouters HJCM, Kieneker LM, van der Klauw MM, van der Meer P, Wolffenbuttel BHR, Gaillard CAJM, Kootstra-Ros JE, Touw DJ, Huls G, Bakker SJL.

Am J Hematol. 2019 Feb;94(2):E45-E48. doi: 10.1002/ajh.25346. Epub 2018 Nov 27. No abstract available.

PMID:
30417934
4.

Association of Low Urinary Sodium Excretion With Increased Risk of Stroke.

Kieneker LM, Eisenga MF, Gansevoort RT, de Boer RA, Navis G, Dullaart RPF, Joosten MM, Bakker SJL.

Mayo Clin Proc. 2018 Dec;93(12):1803-1809. doi: 10.1016/j.mayocp.2018.05.028. Epub 2018 Sep 20.

PMID:
30244812
5.

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients.

Hofman JMG, Eisenga MF, Diepenbroek A, Nolte IM, van Dam B, Westerhuis R, Bakker SJL, Franssen CFM, Gaillard CAJM.

BMC Nephrol. 2018 Sep 20;19(1):242. doi: 10.1186/s12882-018-1045-8.

6.

Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.

Eisenga MF, Nolte IM, van der Meer P, Bakker SJL, Gaillard CAJM.

BMC Nephrol. 2018 Sep 12;19(1):225. doi: 10.1186/s12882-018-1021-3.

7.

Consumption of fruits and vegetables and cardiovascular mortality in renal transplant recipients: a prospective cohort study.

Sotomayor CG, Gomes-Neto AW, Eisenga MF, Nolte IM, Anderson JLC, de Borst MH, Osté MCJ, Rodrigo R, Gans ROB, Berger SP, Navis GJ, Bakker SJL.

Nephrol Dial Transplant. 2018 Aug 27. doi: 10.1093/ndt/gfy248. [Epub ahead of print]

PMID:
30165500
8.

Effects of erythropoietin on fibroblast growth factor 23 in mice and humans.

Hanudel MR, Eisenga MF, Rappaport M, Chua K, Qiao B, Jung G, Gabayan V, Gales B, Ramos G, de Jong MA, van Zanden JJ, de Borst MH, Bakker SJL, Nemeth E, Salusky IB, Gaillard CAJM, Ganz T.

Nephrol Dial Transplant. 2018 Jul 10. doi: 10.1093/ndt/gfy189. [Epub ahead of print]

PMID:
30007314
9.

Posttransplant muscle mass measured by urinary creatinine excretion rate predicts long-term outcomes after liver transplantation.

Stam SP, Osté MCJ, Eisenga MF, Blokzijl H, van den Berg AP, Bakker SJL, de Meijer VE.

Am J Transplant. 2019 Feb;19(2):540-550. doi: 10.1111/ajt.14926. Epub 2018 Jun 3.

PMID:
29745020
10.

Author Correction: Circulating Haptoglobin and Metabolic Syndrome in Renal Transplant Recipients.

Minović I, Eisenga MF, Riphagen IJ, van den Berg E, Kootstra-Ros J, Frenay AS, van Goor H, Rimbach G, Esatbeyoglu T, Levy AP, Gaillard CAJM, Geleijnse JM, Eggersdorfer ML, Navis GJ, Kema IP, Bakker SJL.

Sci Rep. 2018 Apr 20;8(1):6501. doi: 10.1038/s41598-018-24791-4.

11.

Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.

Leaf DE, Siew ED, Eisenga MF, Singh K, Mc Causland FR, Srivastava A, Ikizler TA, Ware LB, Ginde AA, Kellum JA, Palevsky PM, Wolf M, Waikar SS.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):531-541. doi: 10.2215/CJN.10810917. Epub 2018 Mar 8.

PMID:
29519954
12.

Active Smoking and Hematocrit and Fasting Circulating Erythropoietin Concentrations in the General Population.

Eisenga MF, Kieneker LM, Touw DJ, Nolte IM, van der Meer P, Huls G, Gaillard CAJM, Bakker SJL.

Mayo Clin Proc. 2018 Mar;93(3):337-343. doi: 10.1016/j.mayocp.2018.01.005.

PMID:
29502563
13.

Circulating Haptoglobin and Metabolic Syndrome in Renal Transplant Recipients.

Minović I, Eisenga MF, Riphagen IJ, van den Berg E, Kootstra-Ros J, Frenay AS, van Goor H, Rimbach G, Esatbeyoglu T, Levy AP, Gaillard CAJM, Geleijnse JM, Eggersdorfer ML, Navis GJ, Kema IP, Bakker SJL.

Sci Rep. 2017 Oct 27;7(1):14264. doi: 10.1038/s41598-017-14302-2. Erratum in: Sci Rep. 2018 Apr 20;8(1):6501.

14.

Glomerular filtration rate is associated with free triiodothyronine in euthyroid subjects: Comparison between various equations to estimate renal function and creatinine clearance.

Anderson JLC, Gruppen EG, van Tienhoven-Wind L, Eisenga MF, de Vries H, Gansevoort RT, Bakker SJL, Dullaart RPF.

Eur J Intern Med. 2018 Feb;48:94-99. doi: 10.1016/j.ejim.2017.10.009. Epub 2017 Nov 1.

PMID:
29079274
15.

Redefining Unexplained Anemia in Elderly.

Eisenga MF, Stam SP, Bakker SJL.

JAMA Intern Med. 2017 Sep 1;177(9):1394-1395. doi: 10.1001/jamainternmed.2017.2958. No abstract available.

PMID:
28873184
16.

C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.

Eisenga MF, van Londen M, Leaf DE, Nolte IM, Navis G, Bakker SJL, de Borst MH, Gaillard CAJM.

J Am Soc Nephrol. 2017 Dec;28(12):3639-3646. doi: 10.1681/ASN.2016121350. Epub 2017 Aug 3.

17.

Vitamin C Depletion and All-Cause Mortality in Renal Transplant Recipients.

Sotomayor CG, Eisenga MF, Gomes Neto AW, Ozyilmaz A, Gans ROB, Jong WHA, Zelle DM, Berger SP, Gaillard CAJM, Navis GJ, Bakker SJ.

Nutrients. 2017 Jun 2;9(6). pii: E568. doi: 10.3390/nu9060568.

18.

Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.

van Londen M, Aarts BM, Deetman PE, van der Weijden J, Eisenga MF, Navis G, Bakker SJL, de Borst MH; NIGRAM Consortium.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1301-1310. doi: 10.2215/CJN.10270916. Epub 2017 May 25.

19.

Urinary prednisolone excretion is a determinant of serum hepcidin levels in renal transplant recipients.

Eisenga MF, Dullaart RPF, Berger SP, Touw DJ, Bakker SJL, Gaillard CAJM.

Am J Hematol. 2017 Aug;92(8):E173-E175. doi: 10.1002/ajh.24785. Epub 2017 Jun 9. No abstract available.

20.

High Serum PCSK9 Is Associated With Increased Risk of New-Onset Diabetes After Transplantation in Renal Transplant Recipients.

Eisenga MF, Zelle DM, Sloan JH, Gaillard CAJM, Bakker SJL, Dullaart RPF.

Diabetes Care. 2017 Jul;40(7):894-901. doi: 10.2337/dc16-2258. Epub 2017 May 1.

PMID:
28461454
21.

Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population.

Kieneker LM, Eisenga MF, Joosten MM, de Boer RA, Gansevoort RT, Kootstra-Ros JE, Navis G, Bakker SJ.

PLoS One. 2017 Mar 27;12(3):e0174686. doi: 10.1371/journal.pone.0174686. eCollection 2017.

22.

Definition of functional iron deficiency and intravenous iron supplementation.

Eisenga MF, Bakker SJ, Gaillard CA.

Lancet Haematol. 2016 Nov;3(11):e504. doi: 10.1016/S2352-3026(16)30152-1. No abstract available.

PMID:
27968819
23.

Urinary potassium excretion, renal ammoniagenesis, and risk of graft failure and mortality in renal transplant recipients.

Eisenga MF, Kieneker LM, Soedamah-Muthu SS, van den Berg E, Deetman PE, Navis GJ, Gans RO, Gaillard CA, Bakker SJ, Joosten MM.

Am J Clin Nutr. 2016 Dec;104(6):1703-1711. Epub 2016 Nov 9.

PMID:
27935524
24.

Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.

Daly KP, Stack M, Eisenga MF, Keane JF, Zurakowski D, Blume ED, Briscoe DM.

J Heart Lung Transplant. 2017 Apr;36(4):434-442. doi: 10.1016/j.healun.2016.09.013. Epub 2016 Oct 3.

25.

Iron deficiency, anemia, and mortality in renal transplant recipients.

Eisenga MF, Minović I, Berger SP, Kootstra-Ros JE, van den Berg E, Riphagen IJ, Navis G, van der Meer P, Bakker SJ, Gaillard CA.

Transpl Int. 2016 Nov;29(11):1176-1183. doi: 10.1111/tri.12821. Epub 2016 Sep 13.

26.

Association of hepcidin-25 with survival after kidney transplantation.

Eisenga MF, Dullaart RP, Berger SP, Sloan JH, de Vries AP, Bakker SJ, Gaillard CA.

Eur J Clin Invest. 2016 Dec;46(12):994-1001. doi: 10.1111/eci.12682. Epub 2016 Oct 26.

27.

Simultaneous pentafluorobenzyl derivatization and GC-ECNICI-MS measurement of nitrite and malondialdehyde in human urine: Close positive correlation between these disparate oxidative stress biomarkers.

Hanff E, Eisenga MF, Beckmann B, Bakker SJ, Tsikas D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Feb 1;1043:167-175. doi: 10.1016/j.jchromb.2016.07.027. Epub 2016 Jul 16.

PMID:
27461359
28.

[Parenteral iron therapy in chronic kidney disease or chronic heart failure].

Eisenga MF, Diepenbroek A, Swinkels DW, Bakker SJ, van der Meer P, Gaillard CA.

Ned Tijdschr Geneeskd. 2015;159:A8769. Review. Dutch.

PMID:
26374719

Supplemental Content

Loading ...
Support Center